| pubmed-article:11249902 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0134835 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11249902 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:11249902 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11249902 | pubmed:dateCreated | 2001-3-23 | lld:pubmed |
| pubmed-article:11249902 | pubmed:abstractText | Pre- and post-treatment platelet and soluble P-selectin were measured in a group of patients enrolled in the GUSTO-III study and were correlated with clinical outcomes. A peak in soluble P-selectin levels at 3 hours after thrombolytic therapy and lower baseline platelet P-selectin were associated with successful thrombolysis. | lld:pubmed |
| pubmed-article:11249902 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11249902 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11249902 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11249902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11249902 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11249902 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11249902 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:11249902 | pubmed:author | pubmed-author:O'ConnorC MCM | lld:pubmed |
| pubmed-article:11249902 | pubmed:author | pubmed-author:DalesandroM... | lld:pubmed |
| pubmed-article:11249902 | pubmed:author | pubmed-author:GurbelP APA | lld:pubmed |
| pubmed-article:11249902 | pubmed:author | pubmed-author:SerebruanyV... | lld:pubmed |
| pubmed-article:11249902 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11249902 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11249902 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:11249902 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11249902 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11249902 | pubmed:pagination | 774-7, A7 | lld:pubmed |
| pubmed-article:11249902 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:meshHeading | pubmed-meshheading:11249902... | lld:pubmed |
| pubmed-article:11249902 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11249902 | pubmed:articleTitle | Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. | lld:pubmed |
| pubmed-article:11249902 | pubmed:affiliation | Sinai Hospital, Baltimore, Maryland 21215, USA. pgurbel@sinai-balt.com | lld:pubmed |
| pubmed-article:11249902 | pubmed:publicationType | Journal Article | lld:pubmed |
